Legend Biotech

Website: Legend Biotech
Business Area(s): 


Description: 

Legend Biotech's first product candidate, LCAR-B38M, is a B cell maturation antigen (BCMA)-directed chimeric antigen receptor T (CAR-T) cell therapy. The novel dual-epitope design of the BCMA targeting domain facilitates tight binding to BCMA, which is highly expressed on primary myeloma cells and plasma cells.

Location(s): 
Piscataway NJ
United States
Nanjing
China
Dublin
Ireland